Corrigendum: Sex-differences in oral anticoagulant-related intracerebral hemorrhage

Front Neurol. 2022 Oct 19:13:1055360. doi: 10.3389/fneur.2022.1055360. eCollection 2022.

Josefine Grundtvig^{1

2}, Christian Ovesen¹, Thorsten Steiner^{2

3

4}, Cheryl Carcel⁵, David Gaist⁶, Louisa Christensen^{1

2}, Jacob Marstrand^{1

2}, Per Meden^{1

2}, Sverre Rosenbaum¹, Helle K Iversen^{2

7}, Christina Kruuse^{2

8}, Thomas Christensen⁷, Karen Ægidius⁶, Inger Havsteen⁹, Hanne Christensen^{1

2}

¹ Department of Neurology, Bispebjerg Hospital, Copenhagen, Denmark.
² Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
³ Department of Neurology, Klinikum Frankfurt Höchst, Frankfurt, Germany.
⁴ Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
⁵ The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
⁶ Research Unit for Neurology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
⁷ Department of Neurology, Rigshospitalet, Copenhagen, Denmark.
⁸ Department of Neurology, Herlev Hospital, Copenhagen, Denmark.
⁹ Department of Radiology, Bispebjerg Hospital, Copenhagen, Denmark.

Abstract

[This corrects the article DOI: 10.3389/fneur.2022.832903.].

Keywords: ICH; NOAC; intracerebral hemorrhage (ICH); oral anticoagulation; sex-differences; stroke; stroke in women; vitamin K-antagonist.